Cart
sales@molnova.com
Protionamide
CAS No. 14222-60-7
Protionamide( Tebeform )
Catalog No. M11772 CAS No. 14222-60-7
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 29 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 68 | In Stock |
|
| 1G | 99 | In Stock |
|
Biological Information
-
Product NameProtionamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
-
DescriptionProtionamide (or prothionamide) is a drug used in the treatment of tuberculosis; has also been tested for use in the treatment of leprosy.
-
In Vitro——
-
In Vivo——
-
SynonymsTebeform
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number14222-60-7
-
Formula Weight180.27
-
Molecular FormulaC9H12N2S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 7 mg/mL (38.83 mM); DMSO: 36 mg/mL (199.7 mM)
-
SMILESCCCC1=NC=CC(=C1)C(N)=S
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Projahn M, et al. Antimicrob Agents ChemOthers. 2011 Sep;55(9):4408-1
molnova catalog
related products
-
Biotin-Intermedin (r...
Biotin-Intermedin (rat)
-
Terlipressin
Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
-
Gatipotuzumab
Gatipotuzumab (PankoMab) is a novel humanized monoclonal antibody conjugated to the tumor-associated epitope of mucin 1 (TA-MUC1) with potential anti-tumor activity for the study of recurrent epithelial ovarian cancer.
